Multi-targeted therapy of cancer by niclosamide: A new application for an old drug Y Li, PK Li, MJ Roberts, RC Arend, RS Samant, DJ Buchsbaum Cancer letters 349 (1), 8-14, 2014 | 371 | 2014 |
The wnt/β‐catenin signaling pathway: A potential therapeutic target in the treatment of triple negative breast cancer TD King, MJ Suto, Y Li Journal of cellular biochemistry 113 (1), 13-18, 2012 | 332 | 2012 |
Role of tissue plasminogen activator receptor LRP in hippocampal long-term potentiation M Zhuo, DM Holtzman, Y Li, H Osaka, J DeMaro, M Jacquin, G Bu Journal of Neuroscience 20 (2), 542-549, 2000 | 328 | 2000 |
The YXXL motif, but not the two NPXY motifs, serves as the dominant endocytosis signal for low density lipoprotein receptor-related protein Y Li, MP Marzolo, P Van Kerkhof, GJ Strous, G Bu Journal of Biological Chemistry 275 (22), 17187-17194, 2000 | 285 | 2000 |
Interaction of CED-6/GULP, an adapter protein involved in engulfment of apoptotic cells with CED-1 and CD91/low density lipoprotein receptor-related protein (LRP) HP Su, K Nakada-Tsukui, AC Tosello-Trampont, Y Li, G Bu, PM Henson, ... Journal of Biological Chemistry 277 (14), 11772-11779, 2002 | 284 | 2002 |
Low-density lipoprotein receptor-related protein 1 promotes cancer cell migration and invasion by inducing the expression of matrix metalloproteinases 2 and 9 H Song, Y Li, J Lee, AL Schwartz, G Bu Cancer research 69 (3), 879-886, 2009 | 227 | 2009 |
Niclosamide suppresses cancer cell growth by inducing Wnt co-receptor LRP6 degradation and inhibiting the Wnt/β-catenin pathway W Lu, C Lin, MJ Roberts, WR Waud, GA Piazza, Y Li PloS one 6 (12), e29290, 2011 | 217 | 2011 |
Restoring Wnt/β-catenin signaling is a promising therapeutic strategy for Alzheimer's disease. L Jia, Piña-Crespo J, Y Li Mol Brain 12 (1), 104, 2019 | 213 | 2019 |
Low-density lipoprotein receptor family: endocytosis and signal transduction Y Li, J Cam, G Bu Molecular neurobiology 23, 53-67, 2001 | 193 | 2001 |
Differential functions of members of the low density lipoprotein receptor family suggested by their distinct endocytosis rates Y Li, W Lu, MP Marzolo, G Bu Journal of Biological Chemistry 276 (21), 18000-18006, 2001 | 190 | 2001 |
Inhibition of Wnt/β-catenin pathway by niclosamide: a therapeutic target for ovarian cancer RC Arend, AI Londoño-Joshi, RS Samant, Y Li, M Conner, B Hidalgo, ... Gynecologic Oncology 134 (1), 112-120, 2014 | 182 | 2014 |
The putative tumor suppressor LRP1B, a novel member of the low density lipoprotein (LDL) receptor family, exhibits both overlapping and distinct properties with the LDL … CX Liu, Y Li, LM Obermoeller-McCormick, AL Schwartz, G Bu Journal of Biological Chemistry 276 (31), 28889-28896, 2001 | 167 | 2001 |
Frizzled7 as an emerging target for cancer therapy TD King, W Zhang, MJ Suto, Y Li Cellular signalling 24 (4), 846-851, 2012 | 158 | 2012 |
KIFC1 is a novel potential therapeutic target for breast cancer Y Li, W Lu, D Chen, RJ Boohaker, L Zhai, I Padmalayam, K Wennerberg, ... Cancer Biology & Therapy 16 (9), 1316-1322, 2015 | 148 | 2015 |
Suppression of Wnt/β-catenin signaling inhibits prostate cancer cell proliferation W Lu, HN Tinsley, A Keeton, Z Qu, GA Piazza, Y Li European journal of pharmacology 602 (1), 8-14, 2009 | 146 | 2009 |
Dissection of receptor folding and ligand-binding property with functional minireceptors of LDL receptor-related protein LM Obermoeller-McCormick, Y Li, H Osaka, DJ FitzGerald, AL Schwartz, ... Journal of cell science 114 (5), 899-908, 2001 | 139 | 2001 |
Silibinin inhibits Wnt/β-catenin signaling by suppressing Wnt co-receptor LRP6 expression in human prostate and breast cancer cells W Lu, C Lin, TD King, H Chen, RC Reynolds, Y Li Cellular signalling 24 (12), 2291-2296, 2012 | 136 | 2012 |
Sulindac selectively inhibits colon tumor cell growth by activating the cGMP/PKG pathway to suppress Wnt/β-catenin signaling N Li, Y Xi, HN Tinsley, E Gurpinar, BD Gary, B Zhu, Y Li, X Chen, ... Molecular cancer therapeutics 12 (9), 1848-1859, 2013 | 133 | 2013 |
Breast cancer‐derived Dickkopf1 inhibits osteoblast differentiation and osteoprotegerin expression: implication for breast cancer osteolytic bone metastases G Bu, W Lu, CC Liu, K Selander, T Yoneda, C Hall, ET Keller, Y Li International journal of cancer 123 (5), 1034-1042, 2008 | 133 | 2008 |
The low density lipoprotein receptor-related protein 1B retains β-amyloid precursor protein at the cell surface and reduces amyloid-β peptide production JA Cam, CV Zerbinatti, JM Knisely, S Hecimovic, Y Li, G Bu Journal of Biological Chemistry 279 (28), 29639-29646, 2004 | 132 | 2004 |